Research Ethics Committee decision-making in relation to an efficient neonatal trial
File(s)
Author(s)
Gale, CRK
Hyde, MJH
Modi, N
Type
Journal Article
Abstract
Objective
Randomised controlled trials, a gold-standard approach to reduce uncertainties in clinical practice, are growing in cost and are often slow to recruit. We determined the acceptability to United Kingdom (UK) Research Ethics Committees (REC) of approaches to facilitate large, efficient clinical trials.
Design
We developed a protocol in collaboration with parents, for a comparative-effectiveness, randomised controlled trial comparing two widely used blood transfusion practices in preterm infants. We incorporated four approaches to improve recruitment and efficiency: i) point-of-care design using Electronic Patient Records for patient identification, randomisation and data acquisition, ii) short two-page information sheet; iii) explicit mention of possible inclusion benefit; iv) opt-out consent with enrollment as the default. With the support of the UK Health Research Authority, we submitted an identical protocol to 12 UK REC.
Setting
Research Ethics Committees in the UK
Main outcome
Number of REC granting favourable opinions.
Results
The use of Electronic Patient Records was acceptable to all REC; one REC raised concerns about the short parent information sheet, 10 about inclusion benefit and 9 about opt-out consent. Following responses to queries 9 REC granted a favourable final opinion; 3 rejected the application because they considered the opt-out consent process invalid.
Conclusions
A majority of REC in this study consider the use of Electronic Patient Record data, short information sheets, opt-out consent and mention of possible inclusion benefit to be acceptable in neonatal comparative-effectiveness research. We identified a need for guidance for REC in relation to opt-out consent processes. These methods provide opportunity to facilitate large randomised controlled trials.
Randomised controlled trials, a gold-standard approach to reduce uncertainties in clinical practice, are growing in cost and are often slow to recruit. We determined the acceptability to United Kingdom (UK) Research Ethics Committees (REC) of approaches to facilitate large, efficient clinical trials.
Design
We developed a protocol in collaboration with parents, for a comparative-effectiveness, randomised controlled trial comparing two widely used blood transfusion practices in preterm infants. We incorporated four approaches to improve recruitment and efficiency: i) point-of-care design using Electronic Patient Records for patient identification, randomisation and data acquisition, ii) short two-page information sheet; iii) explicit mention of possible inclusion benefit; iv) opt-out consent with enrollment as the default. With the support of the UK Health Research Authority, we submitted an identical protocol to 12 UK REC.
Setting
Research Ethics Committees in the UK
Main outcome
Number of REC granting favourable opinions.
Results
The use of Electronic Patient Records was acceptable to all REC; one REC raised concerns about the short parent information sheet, 10 about inclusion benefit and 9 about opt-out consent. Following responses to queries 9 REC granted a favourable final opinion; 3 rejected the application because they considered the opt-out consent process invalid.
Conclusions
A majority of REC in this study consider the use of Electronic Patient Record data, short information sheets, opt-out consent and mention of possible inclusion benefit to be acceptable in neonatal comparative-effectiveness research. We identified a need for guidance for REC in relation to opt-out consent processes. These methods provide opportunity to facilitate large randomised controlled trials.
Date Issued
2016-09-14
Date Acceptance
2016-07-27
Citation
Archives of Disease in Childhood-Fetal and Neonatal Edition, 2016, 102, pp.F291-F298
ISSN
1468-2052
Publisher
BMJ Publishing Group
Start Page
F291
End Page
F298
Journal / Book Title
Archives of Disease in Childhood-Fetal and Neonatal Edition
Volume
102
Copyright Statement
© 2016 The Authors. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
License URL
Sponsor
The Academy of Medical Sciences
Medical Research Council
Grant Number
N/A
MR/N008405/1
Subjects
Science & Technology
Life Sciences & Biomedicine
Pediatrics
RANDOMIZED-TRIAL
RESEARCH PRIORITIES
MULTICENTER TRIAL
CLINICAL-TRIALS
OPT-IN
INFANTS
CONTEXT
BENEFIT
BOARDS
WASTE
Electronic Health Records
Ethics Committees, Research
Ethics, Research
Informed Consent
Intensive Care, Neonatal
Blood Specimen Collection
Comparative Effectiveness Research
Erythrocyte Transfusion
Humans
Infant, Newborn
Infant, Newborn, Diseases
Neonatology
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Therapeutic Human Experimentation
United Kingdom
WHEAT trial development group
1114 Paediatrics And Reproductive Medicine
Publication Status
Published